Deferasirox Supplier in Peru
DEFRATAJ — WHO-GMP Deferasirox dispersible tablets, supplied direct from the manufacturer to DIGEMID-registered importers.
Supply & Market
Taj Pharma is a global Deferasirox manufacturer in India exporting to Peru, supporting Latin-American hospital networks, ANVISA / COFEPRIS pathway dossiers and private distribution. DEFRATAJ tablets ship from Mumbai (JNPT) to Taj Pharma India Ltd. via Santos, Manzanillo and Callao gateways under cold-chain documentation where required.
The Peru market for iron-chelation therapy is driven by transfusion-dependent thalassemia, sickle-cell disease and myelodysplastic syndromes, where Deferasirox dispersible tablets are widely prescribed under the WHO Essential Medicines List.
Our regulatory and commercial team in Mumbai partners directly with importers, hospital procurement officers and Ministry-of-Health tender desks across Peru — from Lima to regional referral centres — for streamlined supply continuity.
Supply Capability for Peru
DEFRATAJ is supplied to Peru across all five strengths — 100 mg, 125 mg, 250 mg, 400 mg and 500 mg dispersible tablets — in HDPE bottles (30s/60s/100s) and Alu-Alu blister packs. Minimum-order quantities start at 50,000 tablets per strength with a typical lead time of 4–6 weeks from PO confirmation.
- Strengths shipped: 100 mg, 125 mg, 250 mg, 400 mg, 500 mg dispersible tablets
- Pack sizes: bottles (30/60/100 tabs), Alu-Alu blisters (10x10), hospital institutional packs
- MOQ: 50,000 tablets per strength per shipment (mixed pallets supported)
- Lead time: 4–6 weeks ex-Mumbai (JNPT / Nhava Sheva)
- Shelf life: 24 months at 25°C / 60% RH (Zone IVb stability data on file)
- Documents per shipment: CoA, CoO, packing list, invoice, BL/AWB, free-sale certificate
- Private label / co-branding: available with own artwork and brand registration
Cold-chain is not required for dispersible tablets, but climatised containers can be arranged on request for hot-route lanes into Peru.
Regulatory Pathway in Peru
Deferasirox dispersible tablets are registered in Peru with the Direccion General de Medicamentos (DIGEMID). Taj Pharma submits the full CTD dossier (Modules 1–5) along with our WHO-GMP certificate, CoPP, manufacturing licence, plant master file and validated stability data to DIGEMID. Our regulatory desk handles queries, sample submissions and post-approval variations on behalf of local marketing-authorisation holders.
Local agent appointment, secondary packaging in Spanish, and pharmacovigilance reporting are all coordinated from our Mumbai head office. Documentation can be couriered or e-submitted to DIGEMID in Lima.
- CTD dossier (Modules 1–5) ready
- WHO-GMP · ISO 9001 · PIC/S-aligned plant
- CoPP & manufacturing licence on request
- Stability data (long-term & accelerated, Zone IVb)
- Country code
PE· trade currency Peruvian Sol